PreveCeutical Medical Inc. (OTCMKTS:PRVCF – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $0.01 and traded as low as $0.0082. PreveCeutical Medical shares last traded at $0.0082, with a volume of 180,000 shares trading hands.
PreveCeutical Medical Stock Down 23.4%
The business has a fifty day moving average of $0.01 and a 200-day moving average of $0.01.
About PreveCeutical Medical
PreveCeutical Medical Inc is a Canadian life sciences company focused on developing preventive and therapeutic healthcare products that combine naturally derived compounds with biotechnology. Its research programs have centered on novel peptide therapies, cannabinoid-based treatments, gene therapy and drug-delivery technologies.
The company’s development portfolio has included a Sol-Gel platform designed to support the delivery of therapeutic compounds, as well as research into dual-gene therapies and synthetic peptides for potential applications in areas such as chronic disease, pain management and other unmet medical needs.
Recommended Stories
- Five stocks we like better than PreveCeutical Medical
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for PreveCeutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PreveCeutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
